Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer
- PMID: 7114803
Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer
Abstract
25 unselected women with operable breast cancer were followed after radical mastectomy until they died of recurrent cancer (non-survivors), or for 10 years if there was no recurrence (survivors): all the women still alive at 10 years were clinically and radiographically disease-free. Survivors and non-survivors were compared with respect to premastectomy height, and deviation from ideal weight. There were 16 women in the survivor group; at the time of mastectomy, they averaged 11% above ideal weight and only 4 of them (25%) were obese (20% or more above ideal weight). There were 9 women in the non-survival group; they averaged 51% above ideal weight at the time of mastectomy and all of them were obese, as defined. The intergroup difference in mean deviation from ideal weight was very highly significant (P less than 0.0001). Of the 13 women who were obese at mastectomy, only 4 (31%) became survivors, while 100% of the 12 women who were non-obese at mastectomy became survivors; the difference in percent survival was very highly significant (P less than 0.005). Separate evaluation of the roles of height and weight showed that height was not a factor and weight accounted entirely for the observed differences. It appears that maintenance of nonobesity may be a more effective way of decreasing mortality from breast cancer than any other measure proposed to date.
Similar articles
-
The influence of obesity on the disease-free survival in primary breast cancer.Anticancer Res. 1995 Sep-Oct;15(5B):2265-9. Anticancer Res. 1995. PMID: 8572635
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
[Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].Strahlenther Onkol. 1995 Jan;171(1):18-28. Strahlenther Onkol. 1995. PMID: 7839301 German.
-
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].Ai Zheng. 2005 Mar;24(3):327-31. Ai Zheng. 2005. PMID: 15757535 Chinese.
-
[Influence of body weight on the prognosis of breast cancer survivors; nutritional approach after diagnosis].Nutr Hosp. 2013 Nov 1;28(6):1829-41. Nutr Hosp. 2013. PMID: 24506358 Review. Spanish.
Cited by
-
Effects of lifestyle modification after breast cancer treatment: a systematic review protocol.Syst Rev. 2014 Jul 5;3:72. doi: 10.1186/2046-4053-3-72. Syst Rev. 2014. PMID: 24997590 Free PMC article.
-
Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231].BMC Cancer. 2006 Feb 9;6:35. doi: 10.1186/1471-2407-6-35. BMC Cancer. 2006. PMID: 16469108 Free PMC article. Clinical Trial.
-
Fat intake, obesity, and cancer of the breast and endometrium.Med Oncol Tumor Pharmacother. 1985;2(3):125-35. Med Oncol Tumor Pharmacother. 1985. PMID: 4068799
-
Weight gain during adjuvant chemotherapy for breast cancer.Breast Cancer Res Treat. 1985;5(2):195-200. doi: 10.1007/BF01805994. Breast Cancer Res Treat. 1985. PMID: 4016284
-
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy.Breast Cancer Res Treat. 1986;7(1):23-30. doi: 10.1007/BF01886732. Breast Cancer Res Treat. 1986. PMID: 3516262 Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical